Cargando…
The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
Diabetic nephropathy is defined as a decline in the renal function and an increase in the amount of albuminuria (>300 mg/day). The interruption of the renin-angiotensin-aldosterone system (RAAS) by well-established therapies such as angiotensin-converting enzyme inhibitor, angiotensin receptor bl...
Autores principales: | Goenka, Luxitaa, Padmanaban, Raghavan, George, Melvin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011680/ https://www.ncbi.nlm.nih.gov/pubmed/30444201 http://dx.doi.org/10.2174/1574884713666181116100946 |
Ejemplares similares
-
Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
por: Sun, Li‐Jing, et al.
Publicado: (2017) -
Alirocumab in Post ACS Patients - Saving Lives at a Premium
por: George, Melvin, et al.
Publicado: (2022) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Kawanami, Daiji, et al.
Publicado: (2021) -
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
por: Vodošek Hojs, Nina, et al.
Publicado: (2021) -
Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
por: Mende, Christian W., et al.
Publicado: (2023)